¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

¼­¿ï¾Æ»êº´¿ø Á¦10ȸ ¾Æ»ê¾È°ú ½ÉÆ÷Áö¾ö-Â÷Èï¿ø,À±¿µÈñ ±³¼ö´Ô Á¤³âÅðÀÓ±â³ä : 2023-02-05

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
¼­¿ï¾Æ»êº´¿ø Á¦10ȸ ¾Æ»ê¾È°ú ½ÉÆ÷Áö¾ö-Â÷Èï¿ø,À±¿µÈñ ±³¼ö´Ô Á¤³âÅðÀÓ±â³ä : 2023-02-05
±³À°ÀÏÀÚ : 2023-02-05
±³À°Àå¼Ò : µ¿°ü 6Ãþ ´ë°­´ç  
±³À°ÁÖÁ¦ : Á¦10ȸ ¾Æ»ê¾È°ú ½ÉÆ÷Áö¾ö-Â÷Èï¿ø,À±¿µÈñ ±³¼ö´Ô Á¤³âÅðÀÓ±â³ä
ÁÖÃÖ±â°ü : ¼­¿ï¾Æ»êº´¿ø
´ã´çÀÚ : ÇÔÇý¿ø
¿¬¶ôó : 02-3010-6130  
À̸ÞÀÏ : yewonham@amc.seoul.kr      
±³À°Á¾·ù : ¾È°ú      
Âü¼®¿¹»óÀοø : 300¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 7 ½Ã°£ 3ºÐ  
¼¼ºÎ¼ö°­·á : 0¿ø      
ºñ°í       

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 02-05 µ¿°ü ´ë°­´ç 08:20~08:28 Retina as a window for neurodegenerative diseases  ¾ÈÁöÀ±(¼­¿ï´ë) 
±³À°½Ã°£ 02-05 µ¿°ü ´ë°­´ç 08:28~08:36 Genetic testing in inherited retinal dystrophy  ±èÀ±Àü(¿ï»ê´ë) 
±³À°½Ã°£ 02-05 µ¿°ü ´ë°­´ç 08:36~08:44 Gene Therapy for inherited retinal dystrophy  º¯¼®È£(¿¬¼¼´ë) 
±³À°½Ã°£ 02-05 µ¿°ü ´ë°­´ç 08:44~08:52 Extracellular Vesicle (EV): Emerging Therapeutic Opportunities for Retinal Diseases  Sun Young Lee(University of Southern California) 
±³À°½Ã°£ 02-05 µ¿°ü ´ë°­´ç 08:52~09:00 Biophysical and molecular profiling of exosomes in retinal diseases  ÀÌÁØ¿±(¿ï»ê´ë) 
±³À°½Ã°£ 02-05 µ¿°ü ´ë°­´ç 09:00~09:08 Molecular diagnosis of primary vitreoretinal lymphoma  À̽±Ô(¿¬¼¼´ë) 
±³À°½Ã°£ 02-05 µ¿°ü ´ë°­´ç 09:08~09:16 Management of complications in intraocular tumors  ±è¹Î(¿¬¼¼´ë) 
±³À°½Ã°£ 02-05 µ¿°ü ´ë°­´ç 09:16~09:24 Exploring the role of interleukin in retinal and uveal diseases  ¼ÛÁöÈÆ(¾ÆÁÖ´ë) 
±³À°½Ã°£ 02-05 µ¿°ü ´ë°­´ç 09:24~09:32 Biosimilars in ophthalmology  ¿ì¼¼ÁØ(¼­¿ï´ë) 
È޽Ġ02-05 µ¿°ü ´ë°­´ç 09:32~09:45 Coffee break  () 
±âŸ 02-05 µ¿°ü ´ë°­´ç 09:45~09:55 Ceremony  () 
±³À°½Ã°£ 02-05 µ¿°ü ´ë°­´ç 09:55~10:25 Retinal implants for Vision Restoration  Mark S. Humayun(University of Southern California) 
±³À°½Ã°£ 02-05 µ¿°ü ´ë°­´ç 10:25~10:45 Plenary lecture: Diabetic choroid and retina  À±¿µÈñ(¿ï»ê´ë) 
È޽Ġ02-05 µ¿°ü ´ë°­´ç 10:45~11:00 Coffee break & Photo time  () 
±³À°½Ã°£ 02-05 µ¿°ü ´ë°­´ç 11:00~11:08 Epiretinal membrane and metamorphopsia  ¼ÕÁØÈ«(Çѱæ¾È°úº´¿ø) 
±³À°½Ã°£ 02-05 µ¿°ü ´ë°­´ç 11:08~11:16 Imaging analysis for progression and predicting prognosis of idiopathic epiretinal membrane  º¯Àͼö(ºÎ»ê´ë) 
±³À°½Ã°£ 02-05 µ¿°ü ´ë°­´ç 11:16~11:24 Surgical treatment of Epiretinal membrane  ¹Ú±ÔÇü(¼­¿ï´ë) 
±³À°½Ã°£ 02-05 µ¿°ü ´ë°­´ç 11:24~11:32 The Significance of Epiretinal Tissue (LHEP) in Full Thickness Macular Hole  °­¼¼¿õ(¼º±Õ°ü´ë) 
±³À°½Ã°£ 02-05 µ¿°ü ´ë°­´ç 11:32~11:40 Diagnosis and managements of myopic macuopathy  ±èÀ¯Ã¶(°è¸í´ë) 
±³À°½Ã°£ 02-05 µ¿°ü ´ë°­´ç 11:40~11:48 Prevention of atrophic age related macular degeneration  À¯Çü°ï(ÇϴþȰú) 
±³À°½Ã°£ 02-05 µ¿°ü ´ë°­´ç 11:48~11:56 Issues to be considered in pachychoroid neovasculopathy  ÀÌ¿ø±â(´©³×¾È°úº´¿ø) 
±³À°½Ã°£ 02-05 µ¿°ü ´ë°­´ç 11:56~12:04 Hyper-and hypo-perfusion of choriocapillaris in pachychoroid pigment epitheliopathy  ±èÁöÅÃ(Áß¾Ó´ë) 
±³À°½Ã°£ 02-05 µ¿°ü ´ë°­´ç 12:04~12:12 Choroidal angioarchitecture in various retinal diseases  ¹Ú¿µÈÆ(°¡Å縯´ë) 
±³À°½Ã°£ 02-05 µ¿°ü ´ë°­´ç 12:12~12:20 Cell therapy strategies for neovascular AMD  ÀÌÁÖ¿ë(¿ï»ê´ë) 
½Ä»ç 02-05 µ¿°ü ´ë°­´ç 12:20~13:10 Lunch  () 
±³À°½Ã°£ 02-05 µ¿°ü ´ë°­´ç 13:10~13:18 Dry eye: what on earth is Dry eye syndrome?  ¼­°æ·ü(¿¬¼¼´ë) 
±³À°½Ã°£ 02-05 µ¿°ü ´ë°­´ç 13:18~13:26 Microbiome and Ocular surface disease  ±è¹Ì±Ý(¼­¿ï´ë) 
±³À°½Ã°£ 02-05 µ¿°ü ´ë°­´ç 13:26~13:34 The Future of Dry Eye Treatment: from the view of current dry eye treatment  À±°æö(Àü³²´ë) 
±³À°½Ã°£ 02-05 µ¿°ü ´ë°­´ç 13:34~13:42 Deep dive into MGD and its treatment  ¼ÛÁ¾¼®(°í·Á´ë) 
±³À°½Ã°£ 02-05 µ¿°ü ´ë°­´ç 13:42~13:50 Exosome treatment for Dry eye disease  ±èÈ«±Õ(°æºÏ´ë) 
±³À°½Ã°£ 02-05 µ¿°ü ´ë°­´ç 13:50~13:58 Conjunctivomullerectomy for Superior Limbic Keratoconjunctivitis with Ptosis  ¹ÚÁøÇü(¹Ì¼ÒEYE¾È°ú) 
Åä·Ð 02-05 µ¿°ü ´ë°­´ç 13:58~14:08 Discussion  () 
±âŸ 02-05 µ¿°ü ´ë°­´ç 14:08~14:18 Ceremony  () 
±³À°½Ã°£ 02-05 µ¿°ü ´ë°­´ç 14:18~14:48 Toward Corneal Regenerative Medicine  Shigeru Kinoshita(Kyoto Prefectural University of Medicine) 
±³À°½Ã°£ 02-05 µ¿°ü ´ë°­´ç 14:48~15:08 Plenary lecture: My clinical experience in Asan Medical Center  Â÷Èï¿ø(¿ï»ê´ë) 
Åä·Ð 02-05 µ¿°ü ´ë°­´ç 15:08~15:18 Discussion  () 
È޽Ġ02-05 µ¿°ü ´ë°­´ç 15:18~15:38 Coffee break & Photo time  () 
±³À°½Ã°£ 02-05 µ¿°ü ´ë°­´ç 15:38~15:48 Cataract surgery: tips for best cataract surgeon  À̵µÇü(ÀÎÁ¦´ë) 
±³À°½Ã°£ 02-05 µ¿°ü ´ë°­´ç 15:45~15:54 Happy situation after Multifocal IOL Implantation with ABC  ±è¸íÁØ(¸®´º¼­¿ï¾È°ú) 
±³À°½Ã°£ 02-05 µ¿°ü ´ë°­´ç 15:54~16:02 Mastering toric IOLs: astigmatism correction  À¯ÀÎõ(ÀüºÏ´ë) 
±³À°½Ã°£ 02-05 µ¿°ü ´ë°­´ç 16:02~16:10 Introduction of Novel Medical Device for the treatment of dry eye disease after refractive surgery  Á¤Å¿µ(¼º±Õ°ü´ë) 
±³À°½Ã°£ 02-05 µ¿°ü ´ë°­´ç 16:10~16:18 Phakic IOL: Leave it or not  Á¤¼ÒÇâ(°¡Å縯´ë) 
Åä·Ð 02-05 µ¿°ü ´ë°­´ç 16:18~16:28 Discussion  () 
±³À°½Ã°£ 02-05 µ¿°ü ´ë°­´ç 16:28~16:36 DSAEK: Key Steps to Get Started with DSAEK  ±èÀç¿ë(¿ï»ê´ë) 
±³À°½Ã°£ 02-05 µ¿°ü ´ë°­´ç 16:36~16:44 DMEK: For beginners just like Me !!  ÀÌÈÆ(¿ï»ê´ë) 
±³À°½Ã°£ 02-05 µ¿°ü ´ë°­´ç 16:44~16:52 Perfect option for conjunctivochalasia treatment  ÃÖö¿µ(¼º±Õ°ü´ë) 
±³À°½Ã°£ 02-05 µ¿°ü ´ë°­´ç 16:52~17:00 New treatment technique for Recurrent corneal erosion  °íº´ÀÌ(°Ç¾ç´ë) 
±³À°½Ã°£ 02-05 µ¿°ü ´ë°­´ç 17:00~17:08 What Can I do with Amniotic membrane: Corneal perforation  Á¤ÁøÈ£(Á¦ÁÖ´ë) 
Åä·Ð 02-05 µ¿°ü ´ë°­´ç 17:08~17:18 Discussion  () 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ¼­¿ï¾Æ»êº´¿ø Á¦10ȸ ¾Æ»ê¾È°ú ½ÉÆ÷Áö¾ö-Â÷Èï¿ø,À±¿µÈñ ±³¼ö´Ô Á¤³âÅðÀÓ±â³ä : 2023-02-05""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ´ëÇѽºÆ÷Ã÷ÀÇÇÐȸ 2023 ÆÀÇÇÁö¼Ç ¿¬¼ö°­Á : 2023-02-05
´ÙÀ½±Û ÇØ¿î´ë¹éº´¿ø Á¦44ȸ Çѱ¹½ÉÃÊÀ½ÆÄÇÐȸ ¿öÅ©¼¥ : 2023-02-04
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
752 ¼­¿ï 2018³â ´ëÇѹ财Àå¾Ö¿ä½Ç±ÝÇÐȸ Á¦ 23Â÷ Çмú´ëȸ : 2018-09-15 0 953 2018-09-06
751 ¼­¿ï [´ëÇÑÁ¤Çü¿Ü°ú ½ºÆ÷Ã÷ÀÇÇÐȸ] 2018³â Á¦32Â÷ Ãß°èÇмú´ëȸ ¿¬¼ö±³À° : 2018-09-15 0 1,444 2018-09-06
750 ¼­¿ï ´ëÇѳúÁ¹ÁßÇÐȸ 2018 ICSU 2018 & 1st AKJSC Program(9/13~15) : 2018-09-15 0 664 2018-09-06
749 ºÎ»ê ´ëÇÑôÃ߽Űæ¿Ü°úÇÐȸ Á¦32Â÷ Á¤±âÇмú´ëȸ : 2018-09-15 0 1,376 2018-09-06
748 ¼­¿ï ¼¼ºê¶õ½ºº´¿ø ´ëÇÑÇ÷¾×ÇÐȸ AML/MDS ¿¬±¸È¸ ½ÉÆ÷Áö¾ö : 2018-09-15 0 1,017 2018-09-06
747 ¼­¿ï °í·Á´ëÇб³ ±¸·Îº´¿ø Çѱ¹ÀÇ·áÀ±¸®ÇÐȸ ÀÇ»çÁ÷À» À§ÇÑ ÀÇ·áÀ±¸® ½ÉÆ÷Áö¾ö : 2018-09-14 0 634 2018-09-06
746 ´ëÀü °¡Å縯´ëÇб³ ´ëÀü¼º¸ðº´¿ø ´ëÇѹæ»ç¼±Á¾¾çÇÐȸ 9¿ù È£¼­È£³²Áöȸ : 2018-09-14 0 960 2018-09-06
745 ¼­¿ï °¡Å縯ÀÇ´ë ¼­¿ï¼º¸ðº´¿ø ´ëÇѺ´¸®ÇÐȸ º´¸®ÇÐ Áõ·Êº¸°í : 2018-09-14 0 655 2018-09-06
744 ¼­¿ï Çѱ¹ÀÇ·áÁúÇâ»óÇÐȸ °æ¿µÀÚ QI°úÁ¤ : 2018-09-14 0 644 2018-09-06
743 ¼­¿ï 2018³â ´ëÇÑÁ¾¾ç¿Ü°úÇÐȸ Ãß°èÇмú´ëȸ : 2018-09-14 0 555 2018-09-06
742 ¼­¿ï ½Ã¸³µ¿ºÎº´¿ø ¼ö¼úºÎÀ§ °¨¿° : 2018-09-14 0 688 2018-09-06
741 °­¿ø 2018³â ¿øÁÖ¼¼ºê¶õ½º±âµ¶º´¿ø ¿Ü»ó½ÉÆ÷Áö¾ö : 2018-09-14 0 591 2018-09-06
740 ¼­¿ï ´ëÇѳúÁ¹ÁßÇÐȸ 2018 ICSU 2018 & 1st AKJSC Program(9/13~15) : 2018-09-14 0 1,240 2018-09-06
739 ¼­¿ï ¼¼Á¾´ëÇб³ Çѱ¹Ç÷ÀüÁöÇ÷ÇÐȸ Á¦34Â÷ KSTH Ãß°èÇмú´ëȸ : 2018-09-14 0 811 2018-09-06
738 Ãæ³² ¼øõÇâ´ëÇб³ ´ëÇÑÁ¤Çü¿Ü°úÇÐȸ 2018 °í°üÀý °ñÀý ½ÉÆ÷Áö¿ò : 2018-09-14 0 940 2018-09-06
1361 | 1362 | 1363 | 1364 | 1365 | 1366 | 1367 | 1368 | 1369 | 1370
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷